Literature DB >> 9474655

Adverse effects of amiodarone.

M Jafari-Fesharaki1, M M Scheinman.   

Abstract

Amiodarone was introduced 30 years ago as an antianginal agent and subsequently has been used as an antiarrhythmic agent. This drug was initially used for patients with malignant ventricular arrhythmias; however, currently it is being used broadly for rate and rhythm control in patients with atrial fibrillation. At first, amiodarone was primarily used by cardiologists and today it is used throughout the medical profession. Amiodarone therapy can potentially result in a wide range of adverse effects. The majority of these adverse effects are dose related and reversible. The following is a review of the adverse effects and drug interactions of amiodarone along with recommendations for identification and management of these adverse effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474655     DOI: 10.1111/j.1540-8159.1998.tb01068.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

1.  Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease.

Authors:  Shinya Iwasawa; Tomomi Uyeda; Mika Saito; Taku Ishii; Akio Inage; Yuji Hamamichi; Satoshi Yazaki; Tadahiro Yoshikawa
Journal:  Pediatr Cardiol       Date:  2018-03-09       Impact factor: 1.655

2.  Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.

Authors:  G E Kochiadakis; N E Igoumenidis; M E Marketou; M D Kaleboubas; E N Simantirakis; P E Vardas
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

3.  Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.

Authors:  K Ohyama; M Nakajima; M Suzuki; N Shimada; H Yamazaki; T Yokoi
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

4.  An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation.

Authors:  Yuanping Wang; Yuntao Liu; Xia Yan; Dawei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-30       Impact factor: 2.650

5.  Development and Validation of a Novel HPLC Method to Analyse Metabolic Reaction Products Catalysed by the CYP3A2 Isoform: In Vitro Inhibition of CYP3A2 Enzyme Activity by Aspirin (Drugs Often Used Together in COVID-19 Treatment).

Authors:  Amira Hussain; Declan P Naughton; James Barker
Journal:  Molecules       Date:  2022-01-29       Impact factor: 4.411

6.  Anaphylactic Shock as a Rare Side Effect of Intravenous Amiodarone.

Authors:  Aisha Batool; Khadija Batool; Hafsa Habib; Shahzad Chaudhry
Journal:  Cureus       Date:  2022-01-11

7.  Amiodarone-induced neuromyopathy in a geriatric patient.

Authors:  Michael Mark Stanton; Leyla Samii; Gentson Leung; Paula Pearce
Journal:  BMJ Case Rep       Date:  2020-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.